26.01.2016 • NewsElaine BurridgeDKSHDistribution Agreement

DKSH in Distribution Deal with Hampford Research

Switzerland’s DKSH has signed an exclusive agreement with US specialty chemicals manufacturer Hampford Research Inc (HRI).

Under the agreement, DKSH will supply, market and distribute HRI’s photoactive technology products in Europe, North America and Asia.

The deal includes HRI’s entire line of ultraviolet/electron beam (UV/EB) products, including photo acid generators, photo initiators, monomers and co-initiators, as well as any future products created from customer-related product development.

HRI specializes in producing high-purity chemicals used in the electronics, dental, personal care, printing and imaging, and adhesives industries. End products include dental fillings and false teeth, cosmetics and hair products, sunscreen, smart phones, tablets and desktop computers, sticky-backed labels, holographic images and 3D prototype imaging.

Mike Wyrostek, HRI’s director of sales and marketing, said the combination of HRI’s custom manufacturing capabilities and DKSH’s industry knowledge and contacts would result in many successes.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.